CIK 0000715446 · Non-accelerated filer<br>Smaller reporting company
Anixa Biosciences Inc
Sign in to watch- Ticker
- ANIX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Oct 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 112622630
- Phone
- 408-708-9808
- Business address
- 3150 ALMADEN EXPRESSWAY, SUITE 250, SAN JOSE, CA, 95118
- Former names
- ITUS Corp, COPYTELE INC
- 8-K Event Agreement ended
- 8-K Event Material agreement
- 8-K Event Material agreement
- 8-K Event Material agreement
- 424B5 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- 4 Option exercise Director acquired 2,400 shares (option exercise)
- UPLOAD Other SEC-generated Letter
- S-3 Offering Registration Statement
- 8-K Event Other events
- 4 Grant or award Director acquired 50,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 8-K Event Material agreement
- 424B5 Offering Prospectus
- 8-K Event Shareholder vote results
- 4 Grant or award Director acquired 50,000 shares (grant or award)
- 4 Grant or award Director acquired 50,000 shares (grant or award)
- 4 Grant or award Director acquired 50,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
Page 17 of 50 · 983 filings